That's according to a European official who spoke to Reuters.

這是一位向路透社透露的歐洲官員的說法。

The U.

U.

S pharmaceutical giant is supposed to supply 55 million doses in the second quarter, but the firm has reportedly informed Brussels that it's facing issues which could complicate that plan.

S製藥巨頭應該在第二季度提供5500萬劑量，但據報道，該公司已通知布魯塞爾，它面臨的問題可能使該計劃複雜化。

The problems concern the supply of vaccine, ingredients and equipment.

這些問題涉及疫苗、原料和設備的供應。

J and J is said to be under stress to meet the target, though it hasn't said it's impossible.

據悉，J和J雖然沒有說不可能實現目標，但壓力很大。

The company's vaccine is set to be approved within days by the blocks regulator.

該公司的疫苗將在幾天內獲得區塊監管機構的準許。

EU deliveries could then start in April with a goal of 200 million doses this year.

歐盟就可以在4月開始交付，今年的目標是2億劑。

The vaccine has already been rolled out in the US, though March delivery forecasts there have been cut.

該疫苗已經在美國推廣，不過那裡的3月交付預測已經被削減。

There was no official comment on the Reuters report from the E, U or J and J.

對於路透社的報道，E、U、J三家官方沒有發表評論。

Any DeLay would further complicate EU vaccination plans, which have been hit by bumpy supplies from other makers.

任何迪雷都會使歐盟的疫苗接種計劃進一步複雜化，歐盟的疫苗接種計劃受到了其他製造商供應的顛簸。

AstraZeneca cut its planned first quarter deliveries by more than a half.

阿斯利康將第一季度的計劃交付量削減了一半以上。